| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/08/2005 | US6852726 Such as 1-(4,5-dihydro-1H-imidazol-2-ylmethyl)-3-methanesulfonyl-2-methyl-1H-indole for preventing/treating disorders modulated by alpha-1A/L adrenoceptors such as urinary incontinence and sexual disorders |
| 02/08/2005 | US6852725 Imidazolyl derivatives |
| 02/08/2005 | US6852724 Administering a sustained release drug dosage-form including >5.0% by weight ranolazine in no more than two tablets per dose to maintain ranolazine plasma levels at a >850 ng base/mL for >24 hours; methacrylic acid copolymer binder |
| 02/08/2005 | US6852722 Administering a growth hormone secretagogue. |
| 02/08/2005 | US6852721 Compounds capable of activating nicotinic cholinergic receptors; N-aryl diazabicyclic compounds such as (1S,4S)-2-(5-(3-methoxyphenoxy)-3-pyridyl)-2,5-diazabicyclo(2. 2.1)-heptane; treating central nervous system disorders |
| 02/08/2005 | US6852720 Thiazol-2-yl-imine compounds as PDE-7 inhibitors |
| 02/08/2005 | US6852719 Glucocorticoid receptor modulators |
| 02/08/2005 | US6852718 Selective 5-HT2A antagonists useful in treatment or prevention of CNS conditions |
| 02/08/2005 | US6852717 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor; for use in therapy of diseases and pathological conditions involving inflammation such as chronic inflammatory disease |
| 02/08/2005 | US6852716 Central nervous system disorders; psychological disorders |
| 02/08/2005 | US6852715 Formula (1) wherein R1 is a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or an alkoxy group having 1 to 6 carbon atoms; and R2 is a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or an alkoxy group having 1 to 6 carbon |
| 02/08/2005 | US6852714 (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties |
| 02/08/2005 | US6852712 Controlling cell differentiation; antiinflammatory agents |
| 02/08/2005 | US6852711 HIV protease inhibitors |
| 02/08/2005 | US6852710 Antitumor agents, anticancer agents |
| 02/08/2005 | US6852708 Use of hyaluronic acid and forms to prevent the narrowing of the vascular walls |
| 02/08/2005 | US6852707 Using xylobiose or xylooligosaccharide containing xylobiose as a main ingredient in place of lactulose, there is provided a blood ammonia lowering agent, a therapeutic agent of hyperammonemia or a therapeutic agent of hepatic |
| 02/08/2005 | US6852706 Levels of thyroid hormone can be decreased in a mammal to increase healing of heart wounds. The increased wound healing includes rapid re-epithelialization and recovery of normal architecture and function relative to mammals who have not |
| 02/08/2005 | US6852701 Sulfamate compound |
| 02/08/2005 | US6852698 Free radical scavengers or promoters thereof as therapeutic adjuvants in preterm parturition |
| 02/08/2005 | US6852695 For therapy of hyperglycemic disorders |
| 02/08/2005 | US6852689 Methods for administration of antibiotics |
| 02/08/2005 | US6852518 Glycosyl sulfotransferases GST-4α, GST-4β, and GST-6 |
| 02/08/2005 | US6852509 Anti-P53 single-chain antibody fragments and their uses |
| 02/08/2005 | US6852485 Method for identifying a compound for the treatment of microorganism infections by inhibiting energy storage and utilization in pathogens |
| 02/08/2005 | US6852344 Betel leaf extract |
| 02/08/2005 | US6852337 Carvedilol-galenics |
| 02/08/2005 | US6852336 Analgesics; solid dosage form |
| 02/08/2005 | US6852335 Folic acid in solid dosage forms |
| 02/08/2005 | US6852333 Agents and methods for promoting production gains in animals |
| 02/08/2005 | US6852326 DHEA (dehydroepiandrosterone); for use on human skin treating wrinkles, UV radiation damage, aging |
| 02/08/2005 | US6852312 Biocidal polystyrene hydantoin particles |
| 02/08/2005 | US6852311 Ophthalmic ointments for treating infective eye disease |
| 02/08/2005 | US6852308 Iodinated and/or brominated derivatives of aromatic dihydroxy monomers are prepared and polymerized to form radio-opaque polymers. The monomers may also be copolymerized with other dihydroxy monomers. The iodinated and brominated aromatic |
| 02/08/2005 | CA2471102C Crystal form ii of clarithromycin |
| 02/08/2005 | CA2322900C 2-(hetero)aryl-substituted purin-6-ones as phosphodiesterase inhibitors |
| 02/08/2005 | CA2310294C Composition for and method of preventing or treating breast cancer |
| 02/08/2005 | CA2287316C Process for preparing 6-o-monoesters of castanospermine |
| 02/08/2005 | CA2180103C Gene encoding adseverin |
| 02/08/2005 | CA2164050C Cosmetic compositions containing betulinic acid |
| 02/08/2005 | CA2151383C Stabilized medicinal aerosol solution formulation |
| 02/08/2005 | CA2132711C Liposome encapsulated paclitaxel and a method of using the same |
| 02/08/2005 | CA2130754C Amine derivatives of oxo- and hydroxy-substituted hydrocarbons |
| 02/08/2005 | CA2120001C Flavopereirine-based pharmaceutical composition and use thereof for treating hiv |
| 02/08/2005 | CA2112081C Imidazole compounds, their preparation and use |
| 02/08/2005 | CA2097208C The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy |
| 02/08/2005 | CA2096525C Retroviral protease inhibitors |
| 02/08/2005 | CA2096409C Retroviral protease inhibitors |
| 02/08/2005 | CA2096408C Retroviral protease inhibitors |
| 02/06/2005 | CA2436650A1 Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses |
| 02/03/2005 | WO2005010534A1 Ep1 receptor antagonists for the treatment of benign prostatic hypertrophy and screening method |
| 02/03/2005 | WO2005010481A2 Preparation and use of gold glyconanoparticles |
| 02/03/2005 | WO2005010315A2 Performance aid for pesticide or repellent compositions |
| 02/03/2005 | WO2005010202A2 PHENYL ACETIC ACID DERIVATIVES AS HEPATOCYTE NUCLEAR FACTOR 4α (HNF-4α) MODULATOR COMPOUNDS |
| 02/03/2005 | WO2005010189A1 OLIGONUCLEOTIDE INHIBITING THE EXPRESSION OF StAR-BINDING PROTEIN (SBP) GENE AND METHOD THEREFOR |
| 02/03/2005 | WO2005010164A2 Nucleic acid biomaterials and methods of formation and use |
| 02/03/2005 | WO2005010154A2 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity |
| 02/03/2005 | WO2005010143A2 Methods of treatment and disgnosis using modulators of virus-induced cellular gene sequences |
| 02/03/2005 | WO2005010051A2 Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures |
| 02/03/2005 | WO2005010025A2 Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists |
| 02/03/2005 | WO2005010021A1 Method for obtaining a natural mixture of conjugated equine estrogens |
| 02/03/2005 | WO2005010020A1 Indolopyrrolocabazole derivative and antitumor agent |
| 02/03/2005 | WO2005010017A1 Indolopyrrolocarbazole derivative and antitumor agent |
| 02/03/2005 | WO2005010010A1 Cci-779 isomer c |
| 02/03/2005 | WO2005010003A1 Sulfonyldihydroimid- azopyridinone compounds as 5-hydroxytryptamine-6 ligands |
| 02/03/2005 | WO2005010002A1 Process for the synthesis of zolpidem |
| 02/03/2005 | WO2005010001A1 Nicotinamide derivatives useful as pdea4 inhibitors |
| 02/03/2005 | WO2005009999A1 Process for producing imide compound |
| 02/03/2005 | WO2005009998A1 Pna monomer and precursor |
| 02/03/2005 | WO2005009997A1 3,5 disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| 02/03/2005 | WO2005009996A1 Sulfonyldihydro- benzimidazolone compounds as 5-hydroxytryptamine-6 ligands |
| 02/03/2005 | WO2005009995A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | WO2005009994A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | WO2005009991A1 Process for producing 1,2,4-triazole compound and intermediate therefor |
| 02/03/2005 | WO2005009989A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | WO2005009988A1 Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
| 02/03/2005 | WO2005009987A1 Piperidine compounds and pharmaceutical compositions containing them |
| 02/03/2005 | WO2005009974A1 Imidazole compounds and uses thereof |
| 02/03/2005 | WO2005009971A1 Quinolone derivative or salt thereof |
| 02/03/2005 | WO2005009966A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | WO2005009964A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | WO2005009961A2 Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions |
| 02/03/2005 | WO2005009959A1 Piperidine derivatives as ccr5 receptor modulators |
| 02/03/2005 | WO2005009957A1 Tyrosine kinase inhibitors |
| 02/03/2005 | WO2005009954A2 Method for modulating calcium ion-release-activated calcium ion channels |
| 02/03/2005 | WO2005009951A2 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
| 02/03/2005 | WO2005009950A2 Piperidine derivatives as melanocortin-4 receptor agonists |
| 02/03/2005 | WO2005009949A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 02/03/2005 | WO2005009947A2 Aryl heteroaromatic products, compositions comprising the same and use thereof |
| 02/03/2005 | WO2005009540A1 Perinatal hypoxic-ischemic brain damage treatment |
| 02/03/2005 | WO2005009539A2 Compounds for inflammation and immune-related uses |
| 02/03/2005 | WO2005009510A2 Penetration enhancer combinations for transdermal delivery |
| 02/03/2005 | WO2005009476A1 Intravascular delivery of non-viral nucleic acid |
| 02/03/2005 | WO2005009473A1 Antifungal aerosol external preparation |
| 02/03/2005 | WO2005009471A1 Composition for lowering blood-sugar level |
| 02/03/2005 | WO2005009470A1 Remedy for cardiac failure comprising ask1 inhibitor as the active ingredient and method of screening the same |
| 02/03/2005 | WO2005009468A1 Remedy for cartilage-related diseases |
| 02/03/2005 | WO2005009459A1 Ophthalmic compositions comprising trefoil factor family peptides |
| 02/03/2005 | WO2005009458A1 Use of xmp-629 for the treatment of acne |
| 02/03/2005 | WO2005009452A1 A composition for decreasing the risk of long-haul traveller’s syndrome comprising a mixture of pycnogenol and standardized giger root extract |